NCPA's qAM

qAM

NCPA's take on recent CMS final rule

by NCPA | May 21, 2019

Last week, CMS announced its final rule, Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses. Most notably, CMS declined to take the opportunity to reform pharmacy DIR. NCPA's Advocacy Center team has thoroughly examined the rule and has created a comprehensive summary of the rule and what it means to NCPA members. Here's NCPA's official statement on the 2019 rule.